Related Experiment Video
Updated: Apr 19, 2026
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
Published on: January 6, 2014
Anti-cancer vaccines - a one-hit wonder?
1Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
Abstract:
Immunization against common bacterial and viral diseases has helped prevent millions of deaths worldwide. More recently, the concept of vaccination has been developed into a potentially novel strategy to treat and prevent cancer formation, progression, and spread. Over the past few years, a handful of anti-cancer vaccines have been licensed and approved for use in clinical practice, thus providing a breakthrough in the field. However, the path has not always been easy, with many hurdles that have had to be overcome in order to reach this point. Nevertheless, with more anti-cancer vaccines currently in development, there is still hope that they can eventually become routine tools used in the treatment and prevention of cancer in the future. This review will discuss in detail both types of anti-cancer vaccine presently used in clinical practice - therapeutic and preventive - before considering some of the more promising anti-cancer vaccines that are currently in development. Finally, the issue of side effects and the debate surrounding the overall cost-effectiveness of anti-cancer vaccines will be examined.
Insights
Cancer vaccines represent a significant advancement in oncology, offering new ways to treat and prevent cancer. Ongoing research aims to overcome challenges and establish these innovative immunotherapies as standard cancer care.
Area of Science:
- Oncology
- Immunology
- Vaccinology
Background:
- Vaccination has historically prevented infectious diseases.
- Cancer vaccines are emerging as a novel strategy for cancer treatment and prevention.
- Recent approvals mark a breakthrough, though challenges remain.
Purpose of the Study:
- To review current therapeutic and preventive anti-cancer vaccines.
- To discuss promising anti-cancer vaccines in development.
- To examine side effects and cost-effectiveness of cancer vaccines.
Main Methods:
- Literature review of licensed and developmental anti-cancer vaccines.
- Analysis of clinical applications and research progress.
- Discussion of challenges, side effects, and economic factors.
Main Results:
- A few anti-cancer vaccines are now approved for clinical use.
- Numerous therapeutic and preventive cancer vaccines are under development.
- Significant hurdles have been overcome, but more research is needed.
Conclusions:
- Anti-cancer vaccines represent a promising frontier in cancer care.
- Further development is crucial to overcome challenges and improve accessibility.
- Future research will focus on efficacy, safety, and cost-effectiveness.
More Related Videos
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
Related Concept Videos
01:30Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:27Tumor Immunotherapy
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:57Targeted Cancer Therapies
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies